Consano Bio, Inc. funding
Consano Bio, Inc., a biotechnology company based in Burlington, MA (founded 2024), filed a Form D with the SEC on March 20, 2026 and reported $34.8M raised of a $48.9M offering. It filed 2 new offerings in this period, totaling $51.7M.
Amount raised$34.8M
Offering size$48.9M
Filed with the SECMarch 20, 2026
First saleMarch 6, 2026
IndustryBiotechnology
SecuritiesEquity
LocationBurlington, MA
Founded2024
Entity typeCorporation
Investors so far28
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 20
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| March 20, 2026 | $34.8M | $48.9M | Equity |
| December 12, 2025 | $16.8M | $16.8M | Debt, Security to be acquired on exercise |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care